Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cholesgen
Shanghai, Shanghai, Chinacholesgen.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Cholesgen is in early-stage research and development, focusing on target validation and drug discovery. No clinical results reported yet.
- Therapeutic areas
- GastroenterologyCardiovascularMetabolic DisordersEndocrinology
- Modalities
- Small molecules (inferred)
- Industry
- Biotech
02
Partnerships
AstraZeneca (three-year drug discovery collaboration and licensing agreement signed in June 2023)
Beyond the preview
Go deeper on Cholesgen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cholesgen.